As CD8+ T cells appeared to dominate the immune infiltrate and are thought to play a major role in mediating the anti-tumor response to B16 melanoma, we characterized the activation status of CD8+ tumor-infiltrating lymphocytes (TILs) following anti-TGFβ treatment25. The gene discussed is TGFB1; the disease is melanoma.